Climate Rollbacks: A Recurring American Ploy
Strip away the framing and you're left with this: the Trump administration has again moved to revoke key scientific 'endangerment findings' concerning climate change, specifically targeting regulations that push for cleaner, fuel-efficient vehicles. The official premise involves reducing the cost of new cars, presenting a false dichotomy between consumer affordability and ecological
responsibility, a narrative Deutsche Welle dutifully reported without questioning its historical lineage. This is not a new playbook. In 1990, the Bush administration initially resisted Clean Air Act amendments, citing economic burden, only to later concede after overwhelming evidence linked pollution to severe health crises. Decades earlier, the 1950s saw Detroit actively lobbying against early
emission controls, delaying life-saving measures for years under similar pretexts. The pattern is clear: corporate profits, often through increased sales of less efficient, more polluting products, consistently take precedence, with the human and environmental costs externalized onto the public. The current maneuver, aimed at allowing cheaper, gas-powered vehicles, conveniently overlooks the
estimated 2,200 premature deaths and 2.5 million asthma attacks annually attributed to vehicle emissions in the US, according to a recent American Thoracic Society study. This direct exchange of public health for short-term industrial gain demonstrates a persistent double standard, where abstract economic projections trump concrete public health data, echoing the initial denials of leaded